SOD2 and breast cancer: Contrary to this, other studies have demonstrated that the wild-type alanine phenotype carries a greater risk of prostrate, ovarian and breast cancer, suggesting a pro-tumorigenic role for fully-functional SOD2 in these cancers [144,145,146].